• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

SHISX:US

41.25 USD 0.24 0.59%

As of 19:59:59 ET on 04/15/2014.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHISX)

Year To Date: +0.24% 3-Month: -3.35% 3-Year: +18.31% 52-Week Range: 33.50 - 45.80
1-Month: -6.82% 1-Year: +22.13% 5-Year: +20.71% Beta vs SPX: 0.93

Mutual Fund Chart for SHISX

No chart data available.
  • SHISX:US 41.25
  • 1M
  • 1Y
Interactive SHISX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SHISX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 01-28-2005 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrock.com

Fundamentals for SHISX

NAV (on 2014-04-15) 41.25
Assets (M) (on 2014-04-15) 3,476.37
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment 0.00

Dividends for SHISX

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2013-12-13) 0.03
Dividend Yield (ttm) 9.89

Fees & Expenses for SHISX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.72
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.23

Top Fund Holdings for SHISX

Filing Date: 02/28/2014
Name Position Value % of Total
Biogen Idec Inc 445,700 151,841,076 3.812%
Gilead Sciences Inc 1,800,456 149,059,752 3.742%
Johnson & Johnson 1,473,400 135,729,608 3.407%
Celgene Corp 812,019 130,532,054 3.277%
Pfizer Inc 3,842,340 123,377,537 3.097%
Merck & Co Inc 2,004,600 114,242,154 2.868%
AbbVie Inc 2,120,800 107,969,928 2.710%
Alexion Pharmaceuticals Inc 606,517 107,232,206 2.692%
Bayer AG 717,500 101,741,837 2.554%
Roche Holding AG 312,600 96,249,583 2.416%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil